Analysis of Biological Progression and Regression of HELLP Syndrome in Time

Launched by CHU MOHAMMED VI MARRAKECH · Dec 28, 2024

Keywords

ClinConnect Summary

This clinical trial is studying HELLP syndrome, a serious condition that can occur during pregnancy and is related to high blood pressure and problems with the liver and blood cells. The researchers want to understand how this condition changes over time by looking at certain biological markers in pregnant women who are being treated in the maternal intensive care unit (ICU). This study aims to observe how these markers progress or improve as treatment continues.

To be eligible for this trial, participants must be pregnant women who are admitted to the ICU specifically for biological HELLP syndrome. However, women whose symptoms are caused by other medical conditions, like certain blood disorders, or who have received specific treatments like plasma exchange therapy, cannot participate. If women join the study, they can expect to have their health monitored closely to track changes in their condition, helping researchers learn more about HELLP syndrome and potentially improving care for future patients.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant women who are admitted to the maternal ICU for a biological HELLP syndrome
• Exclusion Criteria:
• • Patients whose biological presentation was attributable to other conditions, such as microangiopathies or leukemia.
• • Patients who benefited from plasma exchange therapy